Mind-mapping for lung cancer: Towards a personalized therapeutics approach

There were over 220,000 people diagnosed with lung cancer and over 160,000 people dying of lung cancer during 2010 alone in the United States. In order to arrive at better control, prevention, diagnosis, and therapeutics for lung cancer, we must be able to personalize the approach towards the diseas...

Full description

Saved in:
Bibliographic Details
Published in:Advances in therapy 2011-03, Vol.28 (3), p.173-194
Main Authors: Mollberg, N., Surati, M., Demchuk, C., Fathi, R., Salama, A. K., Husain, A. N., Hensing, T., Salgia, R.
Format: Article
Language:English
Subjects:
Carcinoma, Non-Small-Cell Lung - therapy
Cardiology
Endocrinology
Humans
Internal Medicine
Lung Neoplasms - therapy
Medicine
Medicine & Public Health
Oncology
Pharmacology/Toxicology
Precision Medicine - methods
Review
Rheumatology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There were over 220,000 people diagnosed with lung cancer and over 160,000 people dying of lung cancer during 2010 alone in the United States. In order to arrive at better control, prevention, diagnosis, and therapeutics for lung cancer, we must be able to personalize the approach towards the disease. Mind-mapping has existed for centuries for physicians to properly think about various “flows” of personalized medicine. We include here the epidemiology, diagnosis, histology, and treatment of lung cancer—in particular, non-small cell lung cancer. As we have new molecular signatures for lung cancer, this is further detailed. This review is not meant to be a comprehensive review, but rather its purpose is to highlight important aspects of lung cancer diagnosis, management, and personalized treatment options.
ISSN:0741-238X
1865-8652
DOI:10.1007/s12325-010-0103-9